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INTRODUCTION Background
Multiple epidemiological studies have described heterologous effects of vaccines on infectious disease susceptibility and all-cause mortality [1] [2] [3] [4] . Bacille CalmetteGuérin (BCG) vaccinated low-birth-weight neonates had a 45% lower all-cause mortality compared to unvaccinated controls in a randomized trial conducted in Guinea Bissau [5] ; and an additional early measles vaccine (MV) at 4.5 months was associated with reduced mortality in the absence of measles infections in a randomized trial in Guinea-Bissau [6] . A recent population-level data analysis suggested that MV protects against all-cause mortality by preventing prolonged immunosuppression caused by wild type measles infection [7] . However, if true, then censoring for measles infection should prevent beneficial effects of MV, which is not the case in numerous epidemiological studies [8] .
A review of all available studies where mortality was assessed in the context of diphtheria-tetanus-whole cell pertussis (DTP) vaccination suggests that DTP is associated with increased mortality, particularly in females [9] . Several observational studies suggest that receiving DTP with MV is associated with higher mortality compared to receiving MV only, with males generally more susceptible [10, 11] .
A systematic review for non-specific effects of vaccines commissioned by WHO concluded that the epidemiological evidence supports beneficial heterologous effects of MV; but found insufficient evidence to confirm or refute deleterious heterologous effects of DTP [12] , although the analytical principles used have been questioned We used state-of-the-art methodology to elucidate the immunological mechanisms that might account for beneficial effects of MV and deleterious effects of DTP in a prospective randomized trial, and further analysed the effect of administering both vaccines simultaneously.
METHODS

Study Subjects
Infants attending for routine vaccination were recruited at four months of age at Sukuta Health Centre, a peri-urban area 20 km from the coast of The Gambia.
Eligibility criteria included being healthy, apyrexial (<37.5°C), normal weight-forage, and all recommended vaccines received to date. The study was approved by the Joint Gambia Government/MRC Ethics Committee (project number SCC1085).
Written informed consent was provided by the parent/guardian of the child.
Study Design
Four month old infants were block randomized to one of three vaccine groups in a prospective unblinded study. At 4 months of age group 1 received their third dose of diphtheria-tetanus-whole cell pertussis (DTP), hepatitis B vaccine (HBV) and oral polio vaccine (OPV); and groups 2 and 3 received HBV and OPV only. Table 1) . Venous blood was collected at nine months immediately before vaccination and 4 weeks later: 4.5mLs into a heparinized tube (7.5 units heparin/mL); 0.5mL into a Paxgene TM tube (Qiagen, Crawley, UK).
Whole blood cultures
Heparinized whole blood was cultured in 100μL aliquots in 96-well U-bottom plates with tetanus toxoid (TT) (10μg/ml, Sanofi Pasteur, France); purified protein derivative (PPD) (10μg/mL, Statens Serum Institute, Denmark); a measles peptide-pool of 122 15mer peptides overlapping by 10 amino acids spanning measles protein haemagglutinin (all 1g/mL final concentration, Sigma-Genosys, UK); heat-killed listeria monocytogenes (HKLM) (10 9 cells/mL) (TLR2 agonist); E. coli K12
lipopolysaccharide protein S (LPS) (1μg/mL) (TLR4 agonist); flagellin (10μg/mL) (TLR5 agonist); and CLO-75 (10μg/mL) (TLR7/8 agonist) (all from InvivoGen, San Diego, USA). Anti-CD3 (αCD3) (5μg/mL, Becton-Dickinson (BD), USA) and anti-CD28 (αCD28) (5μg/mL, eBiosciences, UK) were used as a general T cell stimulus, and medium alone was the negative control. Plates were incubated for 16 hours at 37°C, 5% CO2, centrifuged at 2,000 rpm for 5 minutes and 50μL supernatant collected and stored at -20°C.
Multiplex cytokine assays for plasma and culture supernatants
The 
RESULTS
Cohort characteristics
302 children were randomized at four months of age into vaccine groups ( Fig. 1 ).
Ethnic mix was comparable in the 3 vaccine groups (Table 1) . Weight-for-age z scores, haemoglobin and platelet counts were comparable in all groups and sexes (Table 1) . MV+DTP males had significantly higher total white cell counts and significantly lower lymphocyte counts after vaccination compared to other groups, although 3-way interactions were not significant. Local HIV seroprevalence [17] and helminth infection rates were low [18] and unlikely to be significant confounders.
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Vaccine IgG levels
The expected induction of IgG antibodies to measles occurred in the MV and MV+DTP groups and not the DTP group ( Fig. 2A and B) . Similarly, diphtheria, tetanus and pertussis toxoid responses were boosted in the DTP and MV+DTP groups, but not the MV group (Fig. 2C-H ). Females had higher Ptx antibody levels than males postvaccination (p=0.01) (Figs. 2G and H), but there were no other sex differences.
Plasma cytokine profiles post-vaccination
Plasma cytokine group differences were found for TNF:IL-10, IFN-γ:IL-10, IL-7, PDGF and IP-10 ( Fig. 3 ). The DTP group had significantly lower IL-7 than the MV group (p=0.029) (Fig. 4A ). The DTP group had lower TNF:IL-10 than the other vaccine groups whether for all donors combined, males or females (Fig. 4B ). IFN-γ:IL-10 ratios were also lower in DTP males and females, with high levels in MV+DTP females (Fig. 4C ). MV males had higher TNF:IL-10 and IFN-γ:IL-10 (p=0.039) than MV females (p=0.011). DTP females had lower IP-10 than DTP males (p=0.037) and MV females (p=0.021) (Fig. 4D) . PDGF levels were generally higher in the DTP vaccinated group, and MV females (Fig. 4E ).
Toll-like receptor agonist responses
Cytokine responses were tested to TLR2, 4, 5 and 7/8 in vitro stimulation, but only 
Vaccine-specific cellular responses
Priming of measles-specific cellular responses occurred in the MV and MV+DTP but not DTP groups, with upregulation of IFN-γ:IL-10 and IFN-γ:IL-4 to the measles peptide pool post-vaccination (Fig. 6A) . TT reactivity was low and not boosted in the DTP vaccinated infants for any of the cytokines tested (not shown). There was no evidence of any sex interaction in measles or tetanus specific in vitro reactivity.
Cytokine responses to T cell stimulation
Broad T cell reactivity was assessed by αCD3/αCD28 stimulation. Levels of αCD3/αCD28 stimulated eotaxin declined significantly in the MV+DTP group postvaccination (p<0.001); and post-vaccination levels of eotaxin were lower in this group than the MV (p=0.001) and the DTP groups (p=0.009) (Fig. 6B ).
DTP vaccinated females had significantly lower IL-12(p70) levels than males postvaccination (p=0.022) but not pre-vaccination (p=0.626) (Fig. 6C ). Anti-CD3/αCD28 stimulated IFN-γ:IL-4 declined significantly in the DTP group post-vaccination (p=0.029), and post-vaccination levels were lower in the DTP group compared to the MV (p=0.008) and MV+DTP groups (p=0.005) (Fig. 6D ). The MV+DTP males had significantly increased αCD3/αCD28 stimulated IFN-γ:IL-4 post-vaccination (p=0.042) (Fig. 6E) ; and DTP vaccinated females had significantly lower IFN-γ:IL-4 than males at 10 months (p=0.002) but not baseline (p=0.451) (Fig. 6F) . 7B ) whereas females did not (Fig. 7A ).
Differential whole human genome RNA expression profiles
Ex-vivo gene expression profiles were analysed to gain further insights into mechanisms of heterologous effects of MV and DTP. While a series of significantly differentially expressed genes were identified (Fig. 8A) , after multiple test adjustment only 2 showed statistically significant genes (MV females paired and unpaired -1 probe of unknown function). Therefore, a less stringent explorative approach accepting a high rate of false discovery was taken. Genes were filtered by fold-change expression post-vaccination compared to pre-vaccination for each group for paired and unpaired data for all donors and males and females separately identifying 70 differentially expressed probes with ≥1.5 fold (up-or down-regulated) in one or more groups (Supplementary Table 2 ). There was no differential expression ≥1.5 fold unless vaccine treatment groups were separated by sex. Heat maps of the 70 differentially expressed probes were generated, and clustered by genes and conditions using Pearson's dissimilarity (Fig. 8B) . reactivity via epigenetic upregulation of NOD2 activity on macrophages, which in turn increases pro-inflammatory responses to unrelated pathogens [19] . Therefore a plausible mechanism for DTP-induced TLR4 inhibitory effects is via epigenetic modulation. The tentative down-regulation of predominantly type 1 interferon genes in DTP vaccinated females but not males further supports this theory, since the STAT1 pathway, which is strongly dependent on type 1 interferons, is a pivotal mechanism for 'trained immunity' leading to altered innate memory [20] . There were insufficient differentially expressed genes to generate pathways for the MV males and females, and the MV+DTP females.
M a n u s c r i p t 
